125 related articles for article (PubMed ID: 33316719)
1. Potent leads based on CA-19L, an anti-HIV active HIV-1 capsid fragment.
Tsuji K; Wang R; Kobayakawa T; Owusu KB; Fujino M; Kaneko M; Yamamoto N; Murakami T; Tamamura H
Bioorg Med Chem; 2021 Jan; 30():115923. PubMed ID: 33316719
[TBL] [Abstract][Full Text] [Related]
2. Exploratory studies on CA-15L, an anti-HIV active HIV-1 capsid fragment.
Tsuji K; Owusu KB; Kobayakawa T; Wang R; Fujino M; Kaneko M; Yamamoto N; Murakami T; Tamamura H
Bioorg Med Chem; 2020 Jun; 28(11):115488. PubMed ID: 32305183
[TBL] [Abstract][Full Text] [Related]
3. Development of anti-HIV peptides based on a viral capsid protein.
Mizuguchi T; Ohashi N; Matsumoto D; Hashimoto C; Nomura W; Yamamoto N; Murakami T; Tamamura H
Biopolymers; 2017 Jan; 108(1):. PubMed ID: 27428649
[TBL] [Abstract][Full Text] [Related]
4. The HIV-1 capsid protein as a drug target: recent advances and future prospects.
Domenech R; Neira JL
Curr Protein Pept Sci; 2013 Dec; 14(8):658-68. PubMed ID: 24106962
[TBL] [Abstract][Full Text] [Related]
5. An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors.
Sun L; Zhang X; Xu S; Huang T; Song S; Cherukupalli S; Zhan P; Liu X
Eur J Med Chem; 2021 May; 217():113380. PubMed ID: 33751981
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors.
Zhang X; Sun L; Meuser ME; Zalloum WA; Xu S; Huang T; Cherukupalli S; Jiang X; Ding X; Tao Y; Kang D; De Clercq E; Pannecouque C; Dick A; Cocklin S; Liu X; Zhan P
Eur J Med Chem; 2021 Dec; 226():113848. PubMed ID: 34592608
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitors.
Li J; Jiang X; Dick A; Prakash Sharma P; Chen CH; Rathi B; Kang D; Wang Z; Ji X; Lee KH; Cocklin S; Liu X; Zhan P
Bioorg Med Chem; 2021 Oct; 48():116414. PubMed ID: 34562701
[TBL] [Abstract][Full Text] [Related]
8. Medicinal chemistry strategies of targeting HIV-1 capsid protein for antiviral treatment.
Xu S; Sun L; Huang B; Liu X; Zhan P
Future Med Chem; 2020 Jul; 12(14):1281-1284. PubMed ID: 32483985
[No Abstract] [Full Text] [Related]
9. Structure-activity relationships (SAR) research of thiourea derivatives as dual inhibitors targeting both HIV-1 capsid and human cyclophilin A.
Chen K; Tan Z; He M; Li J; Tang S; Hewlett I; Yu F; Jin Y; Yang M
Chem Biol Drug Des; 2010 Jul; 76(1):25-33. PubMed ID: 20456372
[TBL] [Abstract][Full Text] [Related]
10. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG
PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability.
Xu S; Sun L; Dick A; Zalloum WA; Huang T; Meuser ME; Zhang X; Tao Y; Cherukupalli S; Ding D; Ding X; Gao S; Jiang X; Kang D; De Clercq E; Pannecouque C; Cocklin S; Liu X; Zhan P
Eur J Med Chem; 2022 Jan; 227():113903. PubMed ID: 34653770
[TBL] [Abstract][Full Text] [Related]
12. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
Urano E; Ablan SD; Mandt R; Pauly GT; Sigano DM; Schneider JP; Martin DE; Nitz TJ; Wild CT; Freed EO
Antimicrob Agents Chemother; 2016 Jan; 60(1):190-7. PubMed ID: 26482309
[TBL] [Abstract][Full Text] [Related]
13. Chemical profiling of HIV-1 capsid-targeting antiviral PF74.
Wang L; Casey MC; Vernekar SKV; Do HT; Sahani RL; Kirby KA; Du H; Hachiya A; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
Eur J Med Chem; 2020 Aug; 200():112427. PubMed ID: 32438252
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiviral activities of novel acylhydrazone derivatives targeting HIV-1 capsid protein.
Tian B; He M; Tang S; Hewlett I; Tan Z; Li J; Jin Y; Yang M
Bioorg Med Chem Lett; 2009 Apr; 19(8):2162-7. PubMed ID: 19297155
[TBL] [Abstract][Full Text] [Related]
15. Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography.
Goudreau N; Lemke CT; Faucher AM; Grand-Maître C; Goulet S; Lacoste JE; Rancourt J; Malenfant E; Mercier JF; Titolo S; Mason SW
ACS Chem Biol; 2013 May; 8(5):1074-82. PubMed ID: 23496828
[TBL] [Abstract][Full Text] [Related]
16. Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer.
Xu JP; Branson JD; Lawrence R; Cocklin S
Bioorg Med Chem Lett; 2016 Feb; 26(3):824-828. PubMed ID: 26747394
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities.
Sun L; Huang T; Dick A; Meuser ME; Zalloum WA; Chen CH; Ding X; Gao P; Cocklin S; Lee KH; Zhan P; Liu X
Eur J Med Chem; 2020 Mar; 190():112085. PubMed ID: 32066010
[TBL] [Abstract][Full Text] [Related]
18. Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins.
Kobayakawa T; Yokoyama M; Tsuji K; Boku S; Kurakami M; Fujino M; Ishii T; Miura Y; Nishimura S; Shinohara K; Yamamoto K; Bolah P; Kotani O; Murakami T; Sato H; Tamamura H
Chem Pharm Bull (Tokyo); 2024; 72(1):41-47. PubMed ID: 38171903
[TBL] [Abstract][Full Text] [Related]
19. Insights into the activity of maturation inhibitor PF-46396 on HIV-1 clade C.
Ghimire D; Timilsina U; Srivastava TP; Gaur R
Sci Rep; 2017 Mar; 7():43711. PubMed ID: 28252110
[TBL] [Abstract][Full Text] [Related]
20. Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV-CA Binding Fragments.
Lang S; Fletcher DA; Petit AP; Luise N; Fyfe P; Zuccotto F; Porter D; Hope A; Bellany F; Kerr C; Mackenzie CJ; Wyatt PG; Gray DW
ChemMedChem; 2024 Jul; 19(13):e202400025. PubMed ID: 38581280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
